Open original FDA record ↗Recall record
- FDA identifier
- Z-2330-2016
- Company in FDA record
- Dako Denmark A/S
- FDA record creation date
- Aug 3, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The pH of Target Retrieval Solution in the kit measures 4-5 instead of the correct pH of 9.1.
Source facts
- Action
- A recall notification letter dated 7/6/16 was sent to customers to inform them that Dako is recalling EnVision FLEX+ kit because the pH of Target Retrieval Solution in the kit measures 4-5 instead of the correct pH of 9.1. The letter informs the customers that with a pH of 4-5 instead of pH 9 there could be weak staining, false negative or false positive non-specific staining depending on the antibody used. There is the possibility that this staining could lead to a false result. Customers are to discard the affected product, determine the impact as instructed, and confirmed that they have received replacement kits. Customers are instructed to complete the Device Recall Form and contact local sales representative for any questions regarding the recall notification.
- Initiated
- 2016-07-06
- Root cause
- Process control
- Terminated
- 2016-10-13
- Distribution
- Worldwide Distribution -- US, Canada, and Colombia.
- Recall number
- Z-2330-2016
- Recall status
- Terminated
- CDRH record ID
- 148026
- FDA record created
- 2016-08-03
- Recall event number
- 74608